SCHEMBL30176331

SCHEMBL30176331

COC(=O)Cc1cn(-c2ccc(F)c(C)c2)c2ccc(OCc3ccccc3)cc12

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PLA2G4A P47712 5/20 0.46
PPARD Q03181 3/20 0.45
PPARG P37231 2/20 0.45
PPARA Q07869 2/20 0.45
LTB4R Q15722 1/20 0.44
LTB4R2 Q9NPC1 1/20 0.44
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
PLA2G2A P14555 2/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
SRD5A2 P31213 1/20 0.41
AKR1C3 P42330 1/20 0.41
EDNRB P24530 1/20 0.41
EDNRA P25101 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23886848 1.00 PLA2G4A (0.46) PLA2G4APPARDPPARGPPARALTB4R
SCHEMBL28995420 0.86 PLA2G4A (0.57) PLA2G4ALTB4RLTB4R2
SCHEMBL30176288 0.82 EDNRB (0.45) PPARDPPARGPPARAPLA2G2AMEN1
SCHEMBL23886955 0.82 EDNRB (0.45) PPARDPPARGPPARAPLA2G2AMEN1
SCHEMBL30176351 0.78 CNR1 (0.40) PLA2G4ALTB4RLTB4R2MEN1NPC1
SCHEMBL30337937 0.78 CNR1 (0.40) PLA2G4ALTB4RLTB4R2MEN1NPC1
SCHEMBL23886693 0.78 CNR1 (0.40) PLA2G4ALTB4RLTB4R2MEN1NPC1
SCHEMBL23886720 0.78 PLA2G2A (0.45) LTB4RLTB4R2PLA2G2AMEN1NPC1
SCHEMBL30176307 0.78 PLA2G2A (0.45) LTB4RLTB4R2PLA2G2AMEN1NPC1
SCHEMBL30337929 0.78 CNR1 (0.40) MEN1NPC1RAB9AKMT2ASRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126817-A1 SUBSTITUTED 5-HYDROXYINDOLE COMPOUNDS AS MODULATORS OF ALPHA-1 ANTITRYPSIN Vertex Pharmaceuticals Incorporated (US) 2023-02-08 EP disclosed